These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3261314)

  • 21. Vaccination against Haemophilus influenzae type B.
    Lancet; 1986 May; 1(8489):1074-5. PubMed ID: 2871342
    [No Abstract]   [Full Text] [Related]  

  • 22. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Leung AK; Jadavji T
    J R Soc Health; 1988 Oct; 108(5):180-1. PubMed ID: 3148720
    [No Abstract]   [Full Text] [Related]  

  • 23. The introduction of Haemophilus influenzae B (Hib) vaccine.
    Murphy JF
    Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
    [No Abstract]   [Full Text] [Related]  

  • 24. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Peltola H; Käyhty H; Sivonen A; Mäkelä H
    Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H influenzae in the post-vaccination era.
    Peltola H
    Lancet; 1993 Apr; 341(8849):864-5. PubMed ID: 8096567
    [No Abstract]   [Full Text] [Related]  

  • 26. [When should vaccination against Haemophilus influenzae type b take place?].
    Stickl HA
    Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 28. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
    [No Abstract]   [Full Text] [Related]  

  • 29. [Haemophilus vaccines. Their importance in tropical pediatrics].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland.
    Takala AK; Peltola H; Eskola J
    Laryngoscope; 1994 Jun; 104(6 Pt 1):731-5. PubMed ID: 8196448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination against Haemophilus influenzae b disease.
    Cartwright KA
    BMJ; 1992 Aug; 305(6852):485-6. PubMed ID: 1392989
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.
    Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI
    JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of Haemophilus influenzae type b infections in day care: a public health perspective.
    Fleming DW; Cochi SL; Hull HF; Helgerson SD; Cundiff DR; Broome CV
    Rev Infect Dis; 1986; 8(4):568-72. PubMed ID: 3529312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR
    Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccination against Haemophilus influenzae].
    Huber EG
    Padiatr Padol; 1991; 26(4):203-4. PubMed ID: 1749631
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.
    Peltola H; Käyhty H; Virtanen M; Mäkelä PH
    N Engl J Med; 1984 Jun; 310(24):1561-6. PubMed ID: 6610125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilus influenzae type b vaccine efficacy in the United States.
    Gilsdorf JR
    Pediatr Infect Dis J; 1988 Mar; 7(3):147-8. PubMed ID: 3258658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.